HoloMD Appoints Irene Lang as CEO and Cofounder
The Rockville-based mental health technology firm names a new leader to guide its next stage of clinical growth.
Updated on Oct. 27, 2026 in People
Live Poll
Do you trust AI-powered mental health tools to improve long-term patient care?
HoloMD has named Irene Lang as its new CEO and cofounder, with founder Bruce Alan Kehr transitioning into the role of Chief Medical Innovation Officer. The company intends to scale its human-supervised AI platform and further its efforts in the field of Continuous Precision Psychiatry.
Why it matters
Bruce Alan Kehr sought a leader with proven experience in building products and scaling adoption to accelerate the company’s growth. Lang joins the team as the firm engages investors for its next expansion phase aimed at reaching millions of patients.
A recent 180-day pilot at Banyan Treatment Centers enrolled 138 patients and achieved an 83% retention rate. During the trial, the Dr. Holo platform generated 43 human-reviewed escalations, which included 19 alerts related to potential patient relapses.
The players
Irene Lang
The new CEO and cofounder of HoloMD is an expert in developing machine-learning-based quantitative modeling and decision-support systems.
Bruce Alan Kehr
The founder of HoloMD and long-time practitioner in precision psychiatry has transitioned to the role of Chief Medical Innovation Officer.
HoloMD
A Rockville-based health technology firm that operates the Dr. Holo human-supervised AI platform for psychiatric care.
Banyan Treatment Centers
A treatment provider that conducted a 180-day paid pilot program utilizing the HoloMD technology platform.
Potomac Psychiatry
A clinical practice named the Global Precision Psychiatry Practice of the Year in 2026.
The details
Irene Lang previously co-founded the company Eliza, which was acquired by Spring Health 18 months after its inception. HoloMD combines clinical philosophy with machine-learning-based quantitative modeling to provide human-reviewed risk detection in psychiatric care.
Timeline
October 27, 2026: Irene Lang is appointed CEO and cofounder of HoloMD.
2026: Potomac Psychiatry is recognized as the Global Precision Psychiatry Practice of the Year.
Market Landscape
The move aligns HoloMD with the broader industry trend of integrating human-supervised AI platforms into established clinical psychiatry workflows. This appointment positions the company to compete more effectively by scaling its technical infrastructure against other emerging mental health tech firms.
Patients may eventually see changes in how psychiatric risk is monitored through their providers as the company scales its platform. The shift in leadership is unlikely to have immediate effects on current clinic pricing or consumer access.
The takeaway
HoloMD is pivoting its internal structure to prioritize scaling operations and securing new capital. The firm’s focus remains on establishing Continuous Precision Psychiatry through data-driven risk detection and human-supervised workflows.
Further reading
For more on industry leadership changes, visit the People section.
More information
View the full press release for detailed project information.
Source note: This article includes information reported by VentureBeat.
Live Poll
Do you trust AI-powered mental health tools to improve long-term patient care?
